InsidersTradesSigma
Roivant Sciences Ltd.: management transactions · United States · SEC (Form 4)
SEC:roivant-sciences-ltd-a473e9US·SEC (Form 4)Mcap 20.4Bn€Healthcare
Browse the full directors' dealings record of Roivant Sciences Ltd., a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Roivant Sciences Ltd. has recorded 17 public disclosures. Market capitalisation: €20.4bn. The latest transaction was disclosed on 24 May 2022 — Cession. Among the most active insiders: Kumar Rakhi. Every trade is openly available.
17
Insider Decl.
0
Thresholds
€111,967
1 ops.
Buy Volume
€3m
16 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
28.45 €
Analyst consensus
12 analystsStrong buy
29.50 €Target 35.71 €(+25%)41.00 €
Income statement
Revenue29.1 M€
Gross profit28.1 M€97% margin
Net income−172.0 M€-592.0% margin
Valuation
PER (forward)-24.6x
P/Book4.7x
Beta1.14
Balance sheet & cash
Market cap20.37 Bn€
Total debt100.2 M€
Free Cash Flow−844.0 M€
Debt / Equity2%
Profitability & ownership
ROE-19.1%
ROA-14.5%
% insiders22.8%
% institutions78.0%
Last declaration on 24 May 2022
Declarations17 total
Executives▼Sale◆Signal · 47SEC
€42,41412,127 shares@ €3.49750.0002% mcap36.9% of flow
Common Shares
SEC:0000899243-22-019395:0·
Executives▼Sale◆Signal · 49SEC
€488,919139,791 shares@ €3.49750.0024% mcap29.2% of flow
Common Shares
SEC:0000899243-22-019397:0·
Executives▼Sale40SEC
€477,132136,421 shares@ €3.49750.0023% mcap50.4% of flow
Common Shares
SEC:0000899243-22-019396:0·
Executives▼Sale43SEC
€2,520703 shares@ €3.5840.0000% mcap2.2% of flow
Common Shares
SEC:0000899243-22-015799:0·
Executives▼Sale◆Signal · 46SEC
€30,4968,509 shares@ €3.5840.0001% mcap1.8% of flow
Common Shares
SEC:0000899243-22-015797:0·
Executives▼Sale35SEC
€18,3045,107 shares@ €3.5840.0001% mcap1.9% of flow
Common Shares
SEC:0000899243-22-015798:0·
Executives▲Purchase23SEC
€111,96731,685 shares@ €3.53380.0005% mcap100.0% of flow
Common Shares
SEC:0001104659-22-049930:0·
Ideal exit: 17 Jan 2023 (T+270)
Executives▼Sale44SEC
€10,7802,486 shares@ €4.33620.0001% mcap9.4% of flow
Common Shares
SEC:0000899243-22-013165:0·
Executives▼Sale◆Signal · 47SEC
€146,06933,686 shares@ €4.33620.0007% mcap8.7% of flow
Common Shares
SEC:0000899243-22-013164:0·
Executives▼Sale36SEC
€83,84519,336 shares@ €4.33620.0004% mcap8.9% of flow
Common Shares
SEC:0000899243-22-013166:0·
Executives▼Sale◆Signal · 47SEC
€162,63435,386 shares@ €4.5960.0008% mcap9.7% of flow
Common Shares
SEC:0000899243-22-012701:0·
Executives▼Sale39SEC
€367,88780,045 shares@ €4.5960.0018% mcap38.8% of flow
Common Shares
SEC:0000899243-22-012702:0·
Executives▼Sale◆Signal · 46SEC
€33,4637,281 shares@ €4.5960.0002% mcap29.1% of flow
Common Shares
SEC:0000899243-22-012699:0·
Executives▼Sale44SEC
€9,9512,153 shares@ €4.62180.0000% mcap8.7% of flow
Common Shares
SEC:0000899243-22-011864:0·
Executives▼Sale◆Signal · 48SEC
€379,01782,006 shares@ €4.62180.0019% mcap22.6% of flow
Common Shares
SEC:0000899243-22-011863:0·
Executives▼Sale◆Signal · 49SEC
€468,64492,324 shares@ €5.07610.0023% mcap28.0% of flow
Common Shares
SEC:0000899243-22-010363:0·
Executives▼Sale44SEC
€15,6903,091 shares@ €5.07610.0001% mcap13.7% of flow
Common Shares
SEC:0000899243-22-010364:0·
17 of 17 declarations